» Articles » PMID: 33591377

Pathomechanisms and Therapeutic Opportunities in Radiation-induced Heart Disease: from Bench to Bedside

Overview
Date 2021 Feb 16
PMID 33591377
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer management has undergone significant improvements, which led to increased long-term survival rates among cancer patients. Radiotherapy (RT) has an important role in the treatment of thoracic tumors, including breast, lung, and esophageal cancer, or Hodgkin's lymphoma. RT aims to kill tumor cells; however, it may have deleterious side effects on the surrounding normal tissues. The syndrome of unwanted cardiovascular adverse effects of thoracic RT is termed radiation-induced heart disease (RIHD), and the risk of developing RIHD is a critical concern in current oncology practice. Premature ischemic heart disease, cardiomyopathy, heart failure, valve abnormalities, and electrical conduct defects are common forms of RIHD. The underlying mechanisms of RIHD are still not entirely clear, and specific therapeutic interventions are missing. In this review, we focus on the molecular pathomechanisms of acute and chronic RIHD and propose preventive measures and possible pharmacological strategies to minimize the burden of RIHD.

Citing Articles

Quantitative evaluation of radiation-induced heart disease in patients with lung cancer: a three-dimensional speckle tracking imaging study.

Wang Z, Huang L, Li L, Zhang C, Guo L, Liu Y J Thorac Dis. 2024; 16(9):5742-5754.

PMID: 39444891 PMC: 11494581. DOI: 10.21037/jtd-24-587.


Dexmedetomidine ameliorates x-ray-induced myocardial injury via alleviating cardiomyocyte apoptosis and autophagy.

Zhang R, Xie K, Lian Y, Hong S, Zhu Y BMC Cardiovasc Disord. 2024; 24(1):323.

PMID: 38918713 PMC: 11201331. DOI: 10.1186/s12872-024-03988-8.


The Proteoglycans Biglycan and Decorin Protect Cardiac Cells against Irradiation-Induced Cell Death by Inhibiting Apoptosis.

Gaspar R, Dioszegi P, Nogradi-Halmi D, Erdelyi-Furka B, Varga Z, Kahan Z Cells. 2024; 13(10.

PMID: 38786104 PMC: 11119486. DOI: 10.3390/cells13100883.


Late coronary artery injury following chemoradiotherapy for thymic carcinoma: a case report.

Hu S, Wang J, Cui Z, Zhou Y, Gao D BMC Cardiovasc Disord. 2024; 24(1):269.

PMID: 38778265 PMC: 11110269. DOI: 10.1186/s12872-024-03948-2.


Individual benefit in heart sparing during DIBH-supported left breast radiotherapy.

Gaal S, Kahan Z, Rarosi F, Fodor G, Tolnai J, Deak B Clin Transl Radiat Oncol. 2024; 46:100746.

PMID: 38550309 PMC: 10972839. DOI: 10.1016/j.ctro.2024.100746.


References
1.
Sarkozy M, Kovacs Z, Kovacs M, Gaspar R, Szucs G, Dux L . Mechanisms and Modulation of Oxidative/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia. Front Physiol. 2018; 9:1648. PMC: 6275322. DOI: 10.3389/fphys.2018.01648. View

2.
Darby S, McGale P, Taylor C, Peto R . Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6(8):557-65. DOI: 10.1016/S1470-2045(05)70251-5. View

3.
Christian Rehammar J, Jensen M, McGale P, Lorenzen E, Taylor C, Darby S . Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005. Radiother Oncol. 2017; 123(2):299-305. PMC: 5446317. DOI: 10.1016/j.radonc.2017.03.012. View

4.
Hancock S, Donaldson S, Hoppe R . Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol. 1993; 11(7):1208-15. DOI: 10.1200/JCO.1993.11.7.1208. View

5.
Kma L, Gao F, Fish B, Moulder J, Jacobs E, Medhora M . Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax. J Radiat Res. 2012; 53(1):10-7. PMC: 3616750. DOI: 10.1269/jrr.11035. View